FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

373308008: Local anti-infective (substance)


    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2007. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    1198606016 Local anti-infective (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1211795018 Local anti-infective en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1229204010 Local antiseptic en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1198606016 Local anti-infective (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1198606016 Local anti-infective (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1211795018 Local anti-infective en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1211795018 Local anti-infective en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1229204010 Local antiseptic en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1229204010 Local antiseptic en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Local anti-infective Is a Anti-infective agent (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
    Local anti-infective Is a agent cutané false Inferred relationship Existential restriction modifier (core metadata concept)

    Inbound Relationships Type Active Source Characteristic Refinability Group
    Natamycin [skin] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Nystatin [skin] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Terbinafine hydrochloride [2] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Minor skin infection preparations The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Benzalkonium chloride 50% solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Silver nitrate [disinfectant] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Medicinal product containing cyclic lipopeptide and acting as antibacterial agent (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing daptomycin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing benzocaine and triclosan (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Terbinafine hydrochloride 10 mg/g cutaneous cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Fluocinolone acetonide+clioquinol 0.025%/3% cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Fluocinolone acetonide+clioquinol 0.025%/3% ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Fluocinolone acetonide 250 microgram/g and neomycin sulfate 5 mg/g cutaneous cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Terbinafine hydrochloride 10 mg/mL cutaneous spray The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Neomycin sulfate 25 mg/mL oral solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Mafenide acetate 85mg/g cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Mafenide acetate 5% solution (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Sulconazole nitrate 10 mg/mL cutaneous solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Ciclopirox olamine 1% gel The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Ciclopirox olamine 1% lotion The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Ciclopirox olamine 8% solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Haloprogin 1% cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Haloprogin 10 mg/mL cutaneous solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Oxiconazole nitrate 1% cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Oxiconazole nitrate 1% lotion The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely nystatin 500000 unit/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Nystatin 1 million unit oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Nystatin 200000 unit oromucosal lozenge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Clioquinol+hydrocortisone 3%/0.5% cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Naftifine hydrochloride 1% gel The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely natamycin 50 milligram/1 milliliter conventional release eye suspension (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Polymyxin B sulfate+bacitracin zinc 10,000u/500u ophthalmic ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Hexachlorophene 30 mg/mL cutaneous emulsion The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Hexachlorophene 3% soap The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely chloroxine 20 milligram/1 milliliter conventional release cutaneous shampoo (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Ciclopirox olamine 1% cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Mafenide acetate 112mg cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Mafenide acetate 5% powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Naftifine hydrochloride 1.0% cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely ciclopirox 80 milligram/1 milliliter conventional release cutaneous solution (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Ciclopirox 0.77% gel The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Ciclopirox 0.77% lotion The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Ciclopirox 0.77% cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Povidone-iodine 10% The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Miconazole nitrate 200 mg vaginal pessary The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Miconazole nitrate 200mg/sup pessary The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Benzoyl peroxide 10% The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely benzoyl peroxide 100 microgram/1 milligram conventional release cutaneous gel (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Benzoyl peroxide 4% lotion The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Benzoyl peroxide 3% gel The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Benzoyl peroxide 4% gel The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Benzoyl peroxide 8% gel The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Benzoyl peroxide 8% lotion The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Benzoyl peroxide 8% cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Benzoyl peroxide 10% cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Benzoyl peroxide 5% (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Benzoyl peroxide 6% gel The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Nystatin 100 unit/mg cutaneous powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Triclosan 0.1% liquid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Nystatin 100 unit/g cutaneous ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Miconazole nitrate 2%wv cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Miconazole nitrate 200mg cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely terbinafine (as terbinafine hydrochloride) 10 milligram/1 gram conventional release cutaneous solution (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Silver sulfadiazine 10mg/g cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Mupirocin calcium 2% cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Benzoyl peroxide 7% (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Povidone-iodine 10% liquid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Benzoyl peroxide 3% The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Natamycin 5% suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Tetracycline hydrochloride 1%wv suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Tetracycline hydrochloride 1% ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Polymyxin b sulfate 100% powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Bacitracin zinc + neomycin sulfate + polymyxin b sulfate 400unt/3.5gm/10000unt ointment (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Bacitracin zinc + polymyxin b sulphate 500unt/10000unt ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Benzoyl peroxide + clindamycin phosphate 50mg/10mg gel The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Benzoyl peroxide + erythromycin 50mg/30mg gel The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Benzoyl peroxide + hydrocortisone 50mg/5mg lotion The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Benzoyl peroxide + sulfur 10%ww/5%ww The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Benzoyl peroxide + sulfur 5%ww/2%ww The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Clioquinol + hydrocortisone + pramoxine hydrochloride 3%ww/1%ww/0.5%ww The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Clioquinol + hydrocortisone 3%ww/0.5%ww cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Clioquinol + hydrocortisone 3%ww/0.5%ww lotion The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Clioquinol + hydrocortisone 30mg/10mg The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Colistin sulfate + hydrocortisone acetate + neomycin sulfate 0ns/10mg/0ns solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Dexamethasone + neomycin sulfate + polymyxin b sulfate 0.1%wv/ns/10000unt ointment (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Dexamethasone + neomycin sulfate + polymyxin b sulphate 0.1%wv/ns/10000unt suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Dexamethasone + neomycin sulphate 1mg/3.5mg ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Dexamethasone sodium phosphate + neomycin sulfate 1mg/3.5gm solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Gramicidin + neomycin sulfate + polymyxin b sulphate 0.025mg/1.75mg/10000unt solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Hexachlorophene + hydrocortisone + menthol 5mg/5mg/1.25mg topical cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Hydrocortisone + neomycin sulfate + polymyxin b sulphate 10mg/5mg/1.6mg suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/5mg/10000unt sol The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Hydrocortisone+neomycin sulfate+polymyxin b sulphate 10mg/5ns/10000unt suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Hydrocortisone + neomycin sulfate + polymyxin b sulphate 10mg/7.5mg/10000unt suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Hydrocortisone + neomycin sulfate + polymyxin b sulphate 10mg/7.5mg/1000unt solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Hydrocortisone + polymyxin b 5mg/10000unt drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Hydrocortisone acetate + neomycin sulfate + polymyxin b sulfate 5mg/3.5mg/10000unit cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Neomycin sulfate + polymyxin b sulfate + prednisolone acetate 0.35%/10000unt/0.5%wv suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Nystatin + triamcinolone acetonide 100000unt/1mg cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)
    Nystatin + triamcinolone acetonide 100000unt/1mg ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Local anti-infective Inferred relationship Existential restriction modifier (core metadata concept)

    Start Previous Page 6 of 7 End


    Reference Sets

    Concept inactivation indicator attribute value reference set (foundation metadata concept)

    POSSIBLY EQUIVALENT TO association reference set

    Back to Start